Fabrication and In Vitro/Vivo Evaluation of Drug Nanocrystals Self-Stabilized Pickering Emulsion for Oral Delivery of Quercetin

Zhe Wang, Bo Dai, Xiao‐Han Tang, Zhi-Hui Che, Fei Hu, Chengying Shen, Wei Wu, Baode Shen, Hailong YuanPharmaceutics 2022 · DOI

TL;DR

This paper introduces a novel drug delivery system called Nanocrystals Self-Stabilized Pickering Emulsion (NSSPE) to overcome the poor oral bioavailability of quercetin (QT). By using QT nanocrystals as both the active ingredient and the stabilizer, they created a stable emulsion that significantly enhances QT's dissolution rate and absorption in vivo.

What Problem Does This Paper Address?

Quercetin (QT) is a plant-derived flavonoid with promising pharmacological effects, including anti-inflammatory and antioxidant properties. However, its therapeutic potential is severely limited by its extremely low solubility in water, which results in poor oral absorption and consequently low bioavailability. Traditional methods to improve the solubility of such poorly soluble drugs, like liposomes or self-microemulsions, often suffer from poor stability, low drug loading capacity, and the need for significant amounts of surfactants, which can have adverse side effects. This paper aims to develop a more stable and effective delivery system for QT that bypasses these limitations.

Methods

The researchers developed a two-step process:

  1. Quercetin Nanocrystal (QT-NC) Fabrication: QT was first processed into nanocrystals (QT-NC) using a high-pressure homogenization method. This technique breaks down larger QT particles into nano-sized crystals.
  2. QT-NSSPE Preparation: These QT-NCs were then used to create a self-stabilized Pickering emulsion (QT-NSSPE). This was achieved through an ultrasound method where the QT-NCs act as solid particle stabilizers, adsorbing at the oil-water interface to form a stable emulsion without the need for additional surfactants. The formulation was optimized using a Box-Behnken design to find the ideal oil volume fraction, QT concentration, and pH.

Characterization techniques included:

  • Fluorescence Microscopy (FM): To visualize the adsorption of QT-NCs on emulsion droplet surfaces.
  • Scanning Electron Microscopy (SEM): To observe the morphology of QT-NCs and the core-shell structure of QT-NSSPE.
  • Differential Scanning Calorimetry (DSC) and X-ray Powder Diffraction (XRD): To analyze the thermal properties and crystalline nature of QT.
  • Physical Stability Tests: Assessed droplet size, creaming index, zeta potential, and QT content over 30 days at different temperatures (4, 25, and 40 °C).
  • In Vitro Release Study: Measured the release rate of QT from QT-NSSPE, QT-NC, and QT coarse powder in a simulated physiological environment.
  • Pharmacokinetic Study in Rats: Evaluated the oral bioavailability of QT-NSSPE compared to QT-NC and QT coarse powder by measuring QT concentrations in rat plasma over time.

Datasets

Not discussed in the paper. The study utilized commercially available quercetin powder and reference standards.

Key Insights and Ideas

  • Self-Stabilization is Key: The core innovation is using the drug itself (in nanocrystal form) as the stabilizer for the emulsion. This eliminates the need for external surfactants or solid stabilizers, which are often the source of toxicity and stability issues in conventional formulations.
  • Core-Shell Structure: QT-NSSPE exhibits a distinct core-shell structure, with an oil core and a shell formed by the QT nanocrystals. This structure likely contributes to both stability and controlled release.
  • Enhanced Dissolution: The nanocrystal form of QT, and its presence within the emulsion, dramatically increases the surface area available for dissolution, leading to a much faster release of QT compared to its coarse powder form.
  • Improved Oral Bioavailability: The combination of enhanced dissolution and the potential for improved absorption due to the emulsion's lipidic nature (similar to lipid-based drug delivery systems) leads to significantly higher QT concentrations in the bloodstream after oral administration.
  • Stability Under Stress: The developed QT-NSSPE demonstrated excellent physical stability over 30 days across a range of temperatures, suggesting good shelf-life potential.

Key Results

  • Optimized Droplet Size: The optimized QT-NSSPE had a droplet size of 10.29 ± 0.44 µm.
  • High Drug Loading: The optimized formulation achieved a drug loading of 5.35 mg·mL⁻¹.
  • Superior In Vitro Release: Within 24 hours, QT-NSSPE released 65.88% of its QT, compared to 50.71% for QT-NC and only 20.15% for QT coarse powder.
  • Significantly Increased Oral Bioavailability: After oral administration in rats, the Area Under the Curve (AUC₀-t) for QT-NSSPE was 2.76 times higher than for QT coarse powder and 1.38 times higher than for QT-NC.
  • Faster Absorption: The time to reach peak plasma concentration (Tmax) was significantly shorter for QT-NSSPE (1.75 h) compared to QT coarse powder (3.33 h) and QT-NC (2.96 h).

Limitations and Future Work

  • Limited In Vivo Data: While the pharmacokinetic study in rats is promising, further studies in larger animal models or humans would be necessary to confirm these findings.
  • Mechanism of Release: While the study suggests an anomalous non-Fickian diffusion mechanism for QT release from QT-NSSPE, further detailed investigations could elucidate this more precisely.
  • Long-Term Stability: Although 30-day stability was demonstrated, longer-term studies would be beneficial for commercialization.
  • Potential for Other Drugs: The authors suggest that this NSSPE approach could be a promising oral delivery system for other poorly soluble drugs, which warrants further exploration.

Summary updated

Abstract

The aim of this study was to develop a new drug nanocrystals self-stabilized Pickering emulsion (NSSPE) for improving oral bioavailability of quercetin (QT). Quercetin nanocrystal (QT-NC) was fabricated by high pressure homogenization method, and QT-NSSPE was then prepared by ultrasound method with QT-NC as solid particle stabilizer and optimized by Box-Behnken design. The optimized QT-NSSPE was characterized by fluorescence microscope (FM), scanning electron micrograph (SEM), X-ray diffraction (XRD), and differential scanning calorimetry (DSC). The stability, in vitro release, and in vivo oral bioavailability of QT-NSSPE were also investigated. Results showed that the droplets of QT-NSSPE with the size of 10.29 ± 0.44 μm exhibited a core-shell structure consisting of a core of oil and a shell of QT-NC. QT-NSSPE has shown a great stability in droplets shape, size, creaming index, zeta potential, and QT content during 30 days storage at 4, 25, and 40 °C. In vitro release studies showed that QT-NSSPE performed a better dissolution behavior (65.88% within 24 h) as compared to QT-NC (50.71%) and QT coarse powder (20.15%). After oral administration, the AUC<sub>0-t</sub> of QT-NSSPE was increased by 2.76-times and 1.38 times compared with QT coarse powder and QT-NC. It could be concluded that NSSPE is a promising oral delivery system for improving the oral bioavailability of QT.
BibTeX
@inproceedings{wang2022fabrication,
  author = {Zhe Wang and Bo Dai and Xiao‐Han Tang and Zhi-Hui Che and Fei Hu and Chengying Shen and Wei Wu and Baode Shen and Hailong Yuan},
  title = {{Fabrication and In Vitro/Vivo Evaluation of Drug Nanocrystals Self-Stabilized Pickering Emulsion for Oral Delivery of Quercetin}},
  booktitle = {Pharmaceutics},
  year = {2022},
  doi = {10.3390/pharmaceutics14050897},
}
Figure